VRXA Stock Summary and Trading Ideas (Veraxa Biotech Holding | NASDAQ:VRXA)

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

What symbol and exchange does Veraxa Biotech Holding shares trade?

Veraxa Biotech Holding trades on the NASDAQ stock market under the symbol VRXA.

What is Veraxa Biotech Holding stock price doing today?

As of July 8, 2026, VRXA stock price declined to $2.76 with 1,661,245 million shares trading.

How much is Veraxa Biotech Holding worth?

VRXA has a market cap of $390.29 million. This is considered a Small Cap stock.

What are the top ETFs holding Veraxa Biotech Holding?

The top ETF exchange traded funds that VRXA belongs to (by Net Assets): ONEQ.

What are the support and resistance levels for Veraxa Biotech Holding (VRXA)?

VRXA support price is $2.21 and resistance is $3.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VRXA shares will trade within this expected range on the day.